Complete clinical trials solution company, Hawthorne Effect, announced today (October 10) announced it had successfully recruited more than 1,000 patients in 48 states plus Hawaii for a study to qualify the prevalence of valvular heart disease (VHD).
This article was contributed by Mark J. King, Vice President, Research and Innovation, Novant Health.
Larger system, partnership with UNC School of Medicine allow clinicians to pursue research opportunities.
Since Novant Health purchased New Hanover Regional Medical Center in 2021, the Coastal region has benefited from increased access to research. The deal included a partnership with UNC Health and the UNC School of Medicine, further expanding Novant Health’s research across the Coastal region. Through that partnership, we are able to offer more patients access to leading-edge research and give more physicians an opportunity to pursue their own studies.
Advancing care through clinical trials
In the clinical trials, our physicians will offer patients with specific heart conditions or cancers an opportunity to participate. If patients opt in to a trial sponsored by a pharmaceutical company and meet eligibility criteria, they have an opportunity to receive advanced treatmen